ArticleThe International journal of eating disorders2025
On the Road to Somewhere: Commentary on Breiner et al., Matheson et al., and Palmer et al.
Article in The International journal of eating disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advancing the Science of Avoidant/Restrictive Food Intake Disorder (ARFID): Six Key Questions.The International journal of eating disorders · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This commentary considers the contribution of three papers (Breiner et al., Matheson et al., and Palmer et al.) that explore very different approaches to the treatment of Avoidant/Restrictive Food Intake Disorder (ARFID). Comparison is made with the development over time of psychological therapies for other eating disorders and how we need to be open to different possible approaches so that we can eventually find our way to the best treatment(s) in the field of ARFID. Following that, summaries of each paper are given, including consideration of their different methodologies, measures, samples, and treatment outcomes. There are also suggestions for future research that expand on the authors' ideas. The literature is clearly still very disparate, as one might expect at this early stage in the development of treatments for the range of ARFID presentations. However, these papers are all valuable pointers as to where the treatment literature on ARFID might be going in the long term.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.